Commodore Capital as of March 31, 2023
Portfolio Holdings for Commodore Capital
Commodore Capital holds 32 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xenon Pharmaceuticals (XENE) | 10.1 | $66M | 1.8M | 35.79 | |
| Miragen Therapeutics (VRDN) | 8.5 | $56M | 2.2M | 25.44 | |
| Merus N V (MRUS) | 8.3 | $54M | 3.0M | 18.40 | |
| Cogent Biosciences (COGT) | 7.8 | $52M | 4.8M | 10.79 | |
| Bellus Health Com New | 7.2 | $47M | 6.6M | 7.20 | |
| Ambrx Biopharma Sponsored Ads | 6.5 | $43M | 4.8M | 8.92 | |
| Enliven Therapeutics (ELVN) | 5.8 | $38M | 1.7M | 21.90 | |
| Akero Therapeutics (AKRO) | 4.6 | $30M | 790k | 38.26 | |
| Nuvalent Inc-a (NUVL) | 4.3 | $28M | 1.1M | 26.09 | |
| Immunovant (IMVT) | 3.4 | $22M | 1.4M | 15.51 | |
| Vera Therapeutics Cl A (VERA) | 3.3 | $22M | 2.8M | 7.76 | |
| Syndax Pharmaceuticals (SNDX) | 2.7 | $18M | 854k | 21.12 | |
| Celldex Therapeutics Com New (CLDX) | 2.7 | $18M | 496k | 35.98 | |
| Cymabay Therapeutics | 2.7 | $18M | 2.0M | 8.72 | |
| Cabaletta Bio (CABA) | 2.3 | $15M | 1.8M | 8.27 | |
| Kura Oncology (KURA) | 2.2 | $15M | 1.2M | 12.23 | |
| Arrowhead Pharmaceuticals (ARWR) | 2.2 | $15M | 575k | 25.40 | |
| Celcuity (CELC) | 2.2 | $14M | 1.4M | 10.25 | |
| Prometheus Biosciences | 2.1 | $14M | 127k | 107.32 | |
| Alpine Immune Sciences | 1.6 | $10M | 1.3M | 7.72 | |
| Day One Biopharmaceuticals I (DAWN) | 1.5 | $9.9M | 740k | 13.37 | |
| Avidity Biosciences Ord (RNA) | 1.4 | $9.1M | 591k | 15.35 | |
| Enanta Pharmaceuticals (ENTA) | 1.3 | $8.8M | 217k | 40.44 | |
| Allakos | 1.3 | $8.5M | 1.9M | 4.45 | |
| Vaxcyte (PCVX) | 1.1 | $7.5M | 200k | 37.48 | |
| Aclaris Therapeutics (ACRS) | 0.8 | $5.1M | 635k | 8.09 | |
| Third Harmonic Bio (THRD) | 0.6 | $4.1M | 993k | 4.12 | |
| Adverum Biotechnologies | 0.5 | $3.6M | 5.0M | 0.72 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $2.5M | 313k | 7.86 | |
| Rezolute Com New (RZLT) | 0.3 | $1.7M | 898k | 1.92 | |
| Acumen Pharmaceuticals (ABOS) | 0.2 | $1.6M | 400k | 4.06 | |
| Dbv Technologies S A Sponsored Adr | 0.0 | $157k | 93k | 1.69 |
